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Abstract. Maternal infection during pregnancy can have lasting effects on neurodevelopment, but the impact of
malaria in pregnancy on child neurodevelopment is unknown. We present a case of a 24-year-old gravida three woman
enrolled at 14 weeks 6 days of gestation in a clinical trial evaluating malaria prevention strategies in pregnancy. She had
two blood samples test positive for Plasmodium falciparum using loop-mediated isothermal amplification before
20 weeks of gestation. At 31 weeks 4 days of gestation, the woman presented with preterm premature rupture of
membranes, and the twins were delivered by cesarean section. Twin A was 1,920 g and Twin B was 1,320 g. Both
placentas testednegative formalaria bymicroscopy, but theplacenta of TwinBhadevidenceof pastmalaria by histology.
The twins’developmentwas assessedusing theBayleyScales of Infant andToddler Development–Third Edition. At 1 year
chronologic age, Twin B had lower scores across all domains (composite scores: cognitive, Twin A [100], Twin B [70];
motor, Twin A [88], Twin B [73]; language, Twin A [109], Twin B [86]). This effect persisted at 2 years chronologic age
(composite scores: cognitive, Twin A [80], Twin B [60]; motor, Twin A [76], Twin B [67]; language, Twin A [77], Twin B [59]).
Infant health was similar over the first 2 years of life. We report differences in neurodevelopmental outcomes in placental
malaria-discordant dizygotic twins. Additional research is needed to evaluate the impact of placental malaria on neu-
rodevelopmental complications. Trial registration number: ClinicalTrials.gov number, NCT02163447. Registered: June
2014, https://clinicaltrials.gov/ct2/show/NCT02163447.
INTRODUCTION
There are emerging data showing that maternal infection
during pregnancy can have lasting effects on child neuro-
development.1 Present evidence suggests that in utero ex-
posure to maternal immune activation can disrupt early
neurodevelopmental processes resulting in subsequent neu-
ropsychiatric and neurological disorders.2 Although most
pregnancies in sub-Saharan Africa are at risk of malaria in
pregnancy (MIP),3 the impact of MIP on child neuro-
development is unknown. Preclinical data from an experi-
mental model of MIP show that in utero exposure to MIP is
associated with persistent neurocognitive deficits in memory
and affective-like behavior compared with unexposed con-
trols, independent of a low birth weight phenotype.4 However,
this has not been evaluated in clinical studies. Here, we de-
scribe neurodevelopmental outcomes associatedwith a set of
dizygotic placental malaria-discordant twins.
CASE REPORT
Between June and October 2014, HIV-uninfected pregnant
womenwere enrolled in a double-blind, randomized, controlled
trial evaluating the safety and efficacy of intermittent preventive
treatment of malaria during pregnancy.5 This study was con-
ducted in Tororo, Eastern Uganda, where malaria transmission
intensity is estimated at 310 infectious bites per person-year,6
and the prevalence of sulfadoxine-pyrimethamine resistance is
high.Womenweremonitored throughout pregnancy for clinical
malaria, and blood samples were collected at monthly
scheduled visits for molecular assessment of Plasmodium fal-
ciparum using loop-mediated isothermal amplification (LAMP).
A 24-year-old gravida three woman was enrolled in the
study at 14weeks 6daysof gestationby ultrasounddating. An
ultrasound scan revealed a twin pregnancy with no size dif-
ferences noted between fetuses. The mother had a hemo-
globin level of 11.0 g/dL, tested negative for malaria by
microscopy, and was randomized to receive three doses of
dihydroartemisinin–piperaquine (DP) in pregnancy (three
tablets of 40 mg dihyroartemisinin and 320 mg of piperaquine
[Duo-Cotecxin, Holley-Cotec] given once a day for three
consecutive days). At 20 weeks of gestation, the mother re-
ceived her first dose of DP. She reported no history of hy-
pertension or diabetes mellitus, and did not drink alcohol or
smoke tobacco during pregnancy. Routine malaria testing
using LAMP revealed that the mother had been positive for
malaria at enrollment (14.9 weeks of gestation) and in the
immediate follow-up sample (16–19 weeks of gestation). All
subsequent tests were negative (Figure 1).
At 31 weeks 4 days, the woman returned to the study clinic
with preterm premature rupture of membranes (PPROM) with
drainage of clear liquid and complaints of lower abdominal
pains. She had no complaints of fever or other associated
symptoms. Her cervix was thin and soft and she was 6 cm
dilated. On examination, the first twin was breech and the
second transverse. Considering the prematurity and the first
twin presenting breech, an emergency cesarean section was
carried out. There were no reported complications during the
cesarean section. The Apgar scores were nine at 1minute and
10 at 5 minutes following birth for both twins. There were no
congenital abnormalities or dysmorphic features detected
and both infants had normal reflexes andmuscle tone. Twin A
was born 1,920 g with a head circumference of 32 cm, and a
length of 43 cm, and Twin B was born 1,320 g with a head
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circumference of 27 cm, and a length of 38 cm. Although the
size discrepancies between twins were notable with a 31.3%
birth weight discordance, the head circumference for both
twins was in the normal range (Twin A, 98.0%; Twin B, 12.3%)
andneitherwas small-for-gestational age (< 10th percentile for
gestational age) according to INTERGROWTH 21st stan-
dards.7 The twins were dichorionic suggesting that twin-to-
twin transfusion syndrome did not contribute to the growth
discordance.8
At delivery, cord blood and placental blood were negative
for malaria parasites by microscopy and LAMP. Placental
blood was collected by making a small incision on the ma-
ternal surface of the placenta within 1 hour of delivery. Pla-
cental tissue was collected for histological assessment as
previously described.5 Briefly, two 1-cm-wide full-thickness
biopsies were collected from each placenta, placed in 10%
neutral buffered formalin, embedded in paraffin wax, sec-
tioned into 3 uM slices, fixed to glass slides, and stained in
0.1% hematoxylin and 1% eosin for 5 and 1 minute re-
spectively, or in 2%Giemsa for 30minutes. For quantification,
1,000 intervillous blood cells were counted under high power.
Percentages of intervillous erythrocytes infected with para-
sites and of monocyte/macrophages containing malarial
pigment were counted. Placental specimens were examined
by three readers. No parasites were detected in either pla-
centabyhistology, but hemozoinwasdetected in theplacenta
of TwinB, indicatingpast placentalmalaria infection. Placental
pathology showed no evidence of intervillous inflammation in
either twin. Chorioamnionitis was assessed by an expert pa-
thologist and there was no evidence of chorioamnionitis for
either twin. Placental weights were not recorded.
Considering the prematurity of the infants, they were
transferred to the Mbale Regional Referral Hospital neonatal
ward where they received routine neonatal care including
phototherapy for jaundice. There is nomedical documentation
of their neonatal care, but the mother did not perceive any
differences in medical care between the twins. The twins were
hospitalized for the same period of time with a similar duration
of phototherapy, similar feeding profiles, and no differential
respiratory distress or apnea reported. According to the
mother, there were no fevers or complications during hospi-
talization or the neonatal period, and the infants were exclu-
sively fed breastmilk with no formula supplementation,
although the larger twin fed more. Additional details related to
history of hypoglycemia, kernicterus, or respiratory distress/
hypoxia in these high-risk infants are not available.
The children were randomized to receive DP every
12 weeks following birth and were followed-up until the age
of 2 years. At the 1 year follow-up visit, the mother reported
delays in sitting/standing/walking, difficulties in learning, and
differences in speech for both twins using the 10 Questions
Questionnaire.9 These findings may be related to the pre-
maturity of the twins as they had a corrected postnatal age of
46.1 weeks (10.6 months) at the time of evaluation (sched-
uled for 12 months chronologic age). The Bayley Scales of
Infant and Toddler Development–Third Edition,10 was used
for evaluation, with Twin B having lower composite scores
across all domains (Table 1). A decline in two standard de-
viations (30 points in overall cognition) was observed be-
tween twins suggesting that the difference is both clinically
and statistically significant. Infant health was similar over the
first year of life. Both twins had anemia diagnosed at a
scheduled follow-up visit (hb < 10 g/dL) and had an out-
patient sick visit for pneumonia. In addition, TwinB had a sick
visit for a 3-day history of fever and a tender fluctuant
swelling on the knee that was drained, and the child was
administered paracetamol and antibiotics. Neither twin had
malaria, an acute diarrheal illness, or was hospitalized.
At the scheduled neurocognitive follow-up appointment at
2 years chronologic age, the developmental difference per-
sistedwith Twin B showing consistent delays across domains
(Table 1). The difference in overall cognitionwas reduced to 20
points (greater thanone standarddeviation). TwinAhada total
of six sick visits over year 2, with two visits for upper respiratory
tract infections, two visits for an acute diarrheal episode, and
was diagnosed with a fungal skin infection and pustular skin
infection. TwinBhada total of nine sick visits over year 2withan
upper respiratory tract infection, sepsis, common cold, an
acute diarrheal episode, fungal skin infection, pustular skin
FIGURE 1. Schedule of study follow-up.Diagramdepictingdocumentedmalaria exposure during pregnancy andmaternal and child interventions
over study period. The infants were delivered at 31.6 weeks of gestation and transferred to Mbale hospital for neonatal care for a week before
discharge. At 1 and 2 year’s postnatal ages the twins were evaluated using the Bayley’s Scales of Infant and Toddler Development–Third Edition.
This figure appears in color at www.ajtmh.org.
TABLE 1
Bayley composite scores over the first 2 years of life
Year 1 Year 2
Twin A Twin B Twin A Twin B
Cognitive 100 70 80 60
Motor 88 73 76 76
Language 109 86 77 59
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infection, awound,bacterial skin infection, andgastritis.Neither
twin hadmalaria or required hospitalization. Comparison of the
twins’ growth over the age of 2 years revealed that Twin B
remainedsmaller thanTwinA,with thedifferencesmost evident
in the second year of life (Figure 2).
DISCUSSION
This case report has limitations. The twins were born pre-
mature in a low-resource setting where complications asso-
ciated with prematurity and low birth weight may have gone
unrecognized because of limitations in clinical and laboratory
monitoring. Furthermore, most of these patients’ histories
were obtained from the mother’s recall. The cause of the
PPROMand labor onset are unknown, but is likely unrelated to
the asymptomatic submicroscopic malaria infection that oc-
curred before 20 weeks of gestation.
Histological examination of the placentas revealed evi-
dence of past infection in one placenta, but not the other.
Placental histopathology is considered the reference standard
for diagnosis of placental malaria, but the sensitivity of his-
tology can be impacted by the quality and number of sections
taken. Although the placentas were collected and processed
according to established protocols, we cannot rule out in-
fection in the other placenta that was missed as a result of
unequal distribution of malaria in the placenta.
As the twins were dizygotic, genetic factors may have
contributed to differences in fetal size, placental susceptibility
to malaria, and neurodevelopment. Furthermore, because
Twin B was born with a very-low birth weight (< 1,500 g), she
was at a higher risk for complications that could have con-
tributed to differences in neurodevelopment. An evaluation
of 119 growth-discordant twin pairs in theNOTESstudy,who
were evaluated between 24 and 42 months of age using the
Bayley Scales and Infant and Toddler Development–Third
Edition, found a consistent neurodevelopmental disadvan-
tage of the smaller twin compared with the larger twin, with
mean differences (95%CI) in composite scores in cognition,
language, and motor development of −1.7 (−3.1, −0.3), −1.8
(−3.3, −0.3), and −2.2 (−4.0, −0.4), respectively.11 Another
study of developmental outcomes at an age of 3 years in
growth-discordant, very low birth weight, premature twins
noted the largest developmental difference in twins with a
growth discordance greater than 30%.12 Given the level of
growth discordance in the twins described in this report, it is
not unexpected that the smaller twin had lower composite
scores in cognition, language, and motor development;
however, the degree of discordance in neurodevelopment
described in this set of twins is considerably larger than
would be expected on the basis of growth discordance
alone, suggesting there are other factors involved in the
developmental differences observed.
This case report highlights placental malaria discordance in
a set of twins in a scenario of documented submicroscopic
infection in the mother where the malaria-exposed infant had
worse birth and neurodevelopmental outcomes. Given the
resource constraints in our setting, we cannot comment on
numerous complications that may have gone unrecognized.
Certainly other prenatal factors (e.g., placental ischemia or
inflammation) or postnatal factors (e.g. discrepancy in risks for
poor outcomes in low birth weight and very low birth weight
infants including intraventricular hemorrhage, hypoglycemia,
hypothermia, respiratory distress, apnea, among others)
could explain the differential neurodevelopmental outcomes.
However, in the absence of clear medical documentation of
differential clinical courses and with clear histopathologic
differences in the placentas for the twins, this case raises in-
teresting questions about the possibility for long-term neu-
rodevelopmental effects arising from in utero infection. This
report highlights a lack of knowledge regarding factors that
contribute to placental malaria susceptibility, and supports
theneed for studies to evaluate the impact ofmalaria exposure
in pregnancy on neurodevelopment.
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